Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May;33(3):e14051.
doi: 10.1111/jsr.14051. Epub 2023 Oct 13.

Effects of the antipsychotic quetiapine on sleep and breathing: a review of clinical findings and potential mechanisms

Cricket Fauska  1 , Tarun Bastiampillai  2   3   4 , Robert J Adams  1   5 , Gary Wittert  6   7 , Danny J Eckert  1 , Kelly A Loffler  1
Affiliations
Review

Effects of the antipsychotic quetiapine on sleep and breathing: a review of clinical findings and potential mechanisms

Cricket Fauska et al. J Sleep Res. 2024 May.

Abstract

Quetiapine is an antipsychotic medication indicated for schizophrenia and bipolar disorder. However, quetiapine also has hypnotic properties and as such is increasingly being prescribed at low doses 'off-label' in people with insomnia symptoms. Pharmacologically, in addition to its dopaminergic properties, quetiapine also modulates multiple other transmitter systems involved in sleep/wake modulation and potentially breathing. However, very little is known about the impact of quetiapine on obstructive sleep apnoea (OSA), OSA endotypes including chemosensitivity, and control of breathing. Given that many people with insomnia also have undiagnosed OSA, it is important to understand the effects of quetiapine on OSA and its mechanisms. Accordingly, this concise review covers the existing knowledge on the effects of quetiapine on sleep and breathing. Further, we highlight the pharmacodynamics of quetiapine and its potential to alter key OSA endotypes to provide potential mechanistic insight. Finally, an agenda for future research priorities is proposed to fill the current key knowledge gaps.

Keywords: insomnia; lung; off‐label prescribing; respiratory physiology; sleep‐disordered breathing; upper airway.

PubMed Disclaimer

References

REFERENCES

    1. Aishah, A., Lim, R., Sands, S. A., Taranto‐Montemurro, L., Wellman, A., Carberry, J. C., & Eckert, D. J. (2021). Different antimuscarinics when combined with atomoxetine have differential effects on obstructive sleep apnea severity. Journal of Applied Physiology, 130(5), 1373–1382. https://doi.org/10.1152/japplphysiol.01074.2020
    1. Altree, T. J., Aishah, A., Loffler, K. A., Grunstein, R. R., & Eckert, D. J. (2022). The norepinephrine reuptake inhibitor reboxetine alone reduces obstructive sleep apnea severity: A double blind, placebo controlled, randomized, cross‐over trial. Journal of Clinical Sleep Medicine, Jcsm, 10256, 85–96. https://doi.org/10.5664/jcsm.10256
    1. Altree, T. J., & Eckert, D. J. (2022). Obstructive sleep apnea endotypes and their postoperative relevance. International Anesthesiology Clinics, 60(2), 1–7. https://doi.org/10.1097/AIA.0000000000000357
    1. Andrulyte, M., & Bjerrum, O. J. (2018). Identifying off‐label prescriptions through data Mining in Danish Community Pharmacy Servers: An exploratory study on desmopressin, diclofenac, Fucidin, mirtazapine and quetiapine. Basic & Clinical Pharmacology & Toxicology, 123(2), 155–160. https://doi.org/10.1111/bcpt.13009
    1. AstraZeneca. (2020). Australian Product Information Seroquel. Retrieved from https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&a...

Publication types

MeSH terms

LinkOut - more resources